The Roar
The Roar

Advertisement

Post-Sharapova dopers may think twice before 'fessing up.

With the Wada hack, drugs in sport just got murkier. (AAP Image/Lukas Coch)
Roar Guru
9th June, 2016
7

Maria Sharapova must be rueing the day she chose to go the ‘classy’ spin by ‘fessing up in a March press conference to her continued use of Meldonium after its banning.

The Russian champion’s positive came from a test sample at January’s Australian Open.

Had she instead chosen the old-school ‘deny and bluster’ route, her plight might have received more sympathy in the subsequent confusion about the drug’s so-called ‘half life’, or elimination period. Other athletes who similarly failed WADA’s test claimed they last took the substance before the banning date of January 1, 2016.

Its Latvian manufacturer then conceded very small amounts could still be detected for many weeks afterwards.

WADA was then forced into a difficult situation and it is not yet clear how much grace it is offering athletes claiming the half-life defence. Much depends on the interpretation of a microgram residual scale, which can indicate when the drug was last taken.

Sharapova’s initial statement made no attempt to suggest she last took the drug while it was legal. One of the sponsors which stuck with her, racquet manufacturer Head, made Sharapova’s case worse when it issued its own press conference acknowledging she had continued taking it in oversight after the banning.

Given the hyper-legalist scrutiny of so many performance-enhancing drug positives, which offers even the most bare-faced doper the whiff of a technical or medical defence, it is hard to see any more athletes leaping to a Sharapova-type mea culpa in future.

Subject to appeal, the multiple Grand Slam singles winner will now serve a two-year ban imposed by the International Tennis Federation, after an independent tribunal reduced the four years the federation had sought to impose.

Advertisement

Sharapova insists she never viewed her decade-long use of the drug in a performance-enhancing light, but that it was used to address a magnesium deficiency, exercise-related fatigue, and a family history of diabetes.

WADA had meldonium on its monitored list for some time before banning, alerting international federal sports bodies whenever their athletes tested positive.

Athletes were reportedly alerted to WADA’s pending intention to ban the drug as far back as September 2015.

close